Trial record 1 of 1 for:
PT-112-101
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02266745 |
Recruitment Status :
Active, not recruiting
First Posted : October 17, 2014
Last Update Posted : April 5, 2024
|
Sponsor:
Promontory Therapeutics Inc.
Information provided by (Responsible Party):
Promontory Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | August 1, 2024 |
Estimated Study Completion Date : | April 1, 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):